Xvivo Perfusion AB (publ) (FRA:3XV)

Xvivo Perfusion AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	558	543	1,344	934	490	799
Market Cap Growth	-56.84%	-59.60%	43.98%	90.53%	-38.66%	-11.00%
Enterprise Value	542	529	1,307	883	462	772
Last Close Price	17.08	17.08	42.15	-	-	-
PE Ratio	239.91	233.59	89.46	113.04	296.26	1007.78
PS Ratio	7.43	7.24	18.73	17.37	13.15	31.80
PB Ratio	2.86	2.78	7.14	5.34	3.82	6.39
P/TBV Ratio	4.12	4.01	10.81	7.84	6.86	10.06
P/FCF Ratio	-	58.16	379.77	3172.09	564.50	-
P/OCF Ratio	59.73	58.16	138.41	224.23	195.98	-
EV/Sales Ratio	7.13	7.05	18.21	16.42	12.40	30.71
EV/EBITDA Ratio	41.80	41.32	135.06	515.41	387.15	-
EV/EBIT Ratio	65.51	64.75	167.53	1818.08	1156.32	-
EV/FCF Ratio	-	56.62	369.29	2998.27	532.54	-
Debt / Equity Ratio	0.06	0.06	0.02	0.02	0.01	0.00
Debt / EBITDA Ratio	0.90	0.90	0.28	1.06	0.51	-
Debt / FCF Ratio	1.23	1.23	0.84	9.61	1.03	-
Net Debt / Equity Ratio	-0.08	-0.08	-0.18	-0.26	-0.16	-0.31
Net Debt / EBITDA Ratio	-1.21	-1.21	-3.44	-27.04	-17.78	33.59
Net Debt / FCF Ratio	-1.66	-1.66	-9.41	-157.29	-24.46	17.66
Asset Turnover	0.34	0.34	0.36	0.30	0.25	0.19
Inventory Turnover	0.89	0.89	1.12	1.23	1.29	1.02
Quick Ratio	3.68	3.68	3.14	4.94	2.60	4.43
Current Ratio	5.77	5.77	4.58	6.15	3.47	5.24
Return on Equity (ROE)	1.18%	1.18%	8.39%	5.44%	1.36%	0.71%
Return on Assets (ROA)	2.31%	2.31%	2.43%	0.17%	0.17%	-0.87%
Return on Invested Capital (ROIC)	2.97%	3.10%	4.80%	0.40%	0.35%	-2.41%
Return on Capital Employed (ROCE)	3.90%	3.90%	4.00%	0.30%	0.30%	-1.30%
Earnings Yield	0.42%	0.43%	1.12%	0.89%	0.34%	0.10%
FCF Yield	-	1.72%	0.26%	0.03%	0.18%	-0.27%
Buyback Yield / Dilution	0.29%	0.29%	-5.73%	-1.39%	-2.04%	-6.49%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.